Best Achievements in Pituitary and Adrenal Diseases in 2020
- Author:
Chang Ho AHN
1
;
Jung Hee KIM
Author Information
- Publication Type:Review Article
- From:Endocrinology and Metabolism 2021;36(1):51-56
- CountryRepublic of Korea
- Language:English
- Abstract: Significant progress in pituitary and adrenal diseases was made in 2020. This review presents major translational and clinical advances in research on pituitary and adrenal diseases, encompassing their epidemiology, pathogenesis, diagnosis, and clinical management. We address the controversy regarding the nomenclature of pituitary neuroendocrine tumors, omics-based molecular classification of pituitary adenomas, and novel drugs for Cushing’s disease in the field of pituitary diseases. In the field of adrenal diseases, we cover big data-driven epidemiology of adrenal tumors, steroid profiling as a new diagnostic tool, and the utility of scoring systems in the decision-making process of managing primary aldosteronism. This brief article will broaden readers’ understanding of pituitary and adrenal diseases.
